Risk Factors of Right Ventricular Dysfunction and Adverse Cardiac Events in Patients with Repaired Tetralogy of Fallot.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
08 10 2021
Historique:
received: 16 08 2021
revised: 01 10 2021
accepted: 02 10 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 26 10 2021
Statut: epublish

Résumé

This study evaluates the risk factors associated with right ventricular (RV) dilation and dysfunction leading to pulmonary valve replacement (PVR) or adverse cardiac events in repaired Tetralogy of Fallot (rToF) patients. Data from all rToF patients who underwent magnetic resonance imaging (MRI) evaluation at our hospital between February 2007 and September 2020 were collected. Three hundred and forty-two patients (60% males, 42% older than 18 years), with a median age of 16 years (IQR 13-24) at the time of MRI, were included. All patients underwent complete repair at a median age of 8 months (IQR 5-16), while palliation was performed in 56 patients (16%). One hundred and forty-four patients (42%) subsequently received pulmonary valve replacement (PVR). At the multivariate analysis, male gender was an independent predictor for significant RV dilation, RV and left ventricular (LV) dysfunction. Transventricular ventricular septal defect (VSD) closure and previous palliation significantly affected LV function and RV size, respectively. Male gender and the transventricular VSD closure were independent predictors for PVR. Male gender and surgical history (palliation, VSD closure approach) significantly affected the long-term outcomes in rToF patients and should be taken into consideration in the follow-up management and in PVR timing in this patient population.

Identifiants

pubmed: 34639849
pii: ijerph181910549
doi: 10.3390/ijerph181910549
pmc: PMC8507852
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : British Heart Foundation
ID : CH/17/1/32804
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/33/31394
Pays : United Kingdom

Références

Eur J Cardiothorac Surg. 2012 Nov;42(5):766-74; discussion 774
pubmed: 23087090
Eur J Cardiothorac Surg. 2011 Sep;40(3):538-42
pubmed: 21354809
J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):855-63
pubmed: 23422886
J Am Coll Cardiol. 2012 Sep 11;60(11):1005-14
pubmed: 22921969
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1698-1709
pubmed: 30840295
Eur Heart J. 2005 Dec;26(24):2721-7
pubmed: 16214832
Circ Cardiovasc Imaging. 2011 Nov;4(6):703-11
pubmed: 21908707
JACC Cardiovasc Imaging. 2020 Aug;13(8):1844-1847
pubmed: 32305481
J Card Surg. 2017 Nov;32(11):712-720
pubmed: 29143377
J Thorac Cardiovasc Surg. 2014 Mar;147(3):889-95
pubmed: 24365272
J Magn Reson Imaging. 2011 May;33(5):1040-6
pubmed: 21509859
Circulation. 2010 Aug 31;122(9):868-75
pubmed: 20713900
J Cardiovasc Med (Hagerstown). 2018 Nov;19(11):613-623
pubmed: 30048301
Pediatr Cardiol. 2013 Jan;34(1):95-104
pubmed: 22669402
Eur J Cardiothorac Surg. 2015 Mar;47(3):527-34
pubmed: 24801339
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2589-95
pubmed: 25173118
Circulation. 2009 Jan 27;119(3):445-51
pubmed: 19139389
J Thorac Cardiovasc Surg. 2009 Jul;138(1):103-8
pubmed: 19577064
JAMA Cardiol. 2017 Jun 1;2(6):678-683
pubmed: 28241248
Circulation. 2007 Jul 31;116(5):545-51
pubmed: 17620511
Circulation. 2013 Oct 22;128(17):1855-7
pubmed: 24065609
Eur J Cardiothorac Surg. 2007 Sep;32(3):462-8
pubmed: 17627832
J Am Coll Cardiol. 2019 Apr 2;73(12):1494-1563
pubmed: 30121240
Cardiol Clin. 2020 Aug;38(3):365-377
pubmed: 32622491
J Cardiovasc Magn Reson. 2015 Apr 18;17:29
pubmed: 25928314
Pediatr Cardiol. 1990 Apr;11(2):61-8
pubmed: 2349143
J Am Coll Cardiol. 2004 Mar 17;43(6):1068-74
pubmed: 15028368
JACC Basic Transl Sci. 2019 Jun 24;4(3):364-384
pubmed: 31312760
Eur Heart J. 2016 Mar 7;37(10):836-9
pubmed: 26685132
J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):23-9
pubmed: 17255812
J Cardiovasc Magn Reson. 2011 Jan 20;13:9
pubmed: 21251297
Circulation. 2001 May 22;103(20):2489-94
pubmed: 11369690
J Magn Reson Imaging. 2008 Jul;28(1):67-73
pubmed: 18581357
J Cardiovasc Magn Reson. 2008 Aug 19;10:40
pubmed: 18713464
Circulation. 2013 Oct 22;128(17):1861-8
pubmed: 24065608

Auteurs

Benedetta Leonardi (B)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Camilla Calvieri (C)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Marco Alfonso Perrone (MA)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Arianna Di Rocco (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Adriano Carotti (A)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Massimo Caputo (M)

Bristol Medical School, University of Bristol, Bristol BS2 8HW, UK.

Aurelio Secinaro (A)

Department of Radiology, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Davide Curione (D)

Department of Radiology, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Maria Giulia Gagliardi (MG)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Paolo Guccione (P)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Sonia Albanese (S)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Lorenzo Galletti (L)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Fabrizio Drago (F)

Department of Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital IRCCS, 00165 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH